Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer, Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04485442
What this trial is testing

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

Who this might be right for
Skin Cancer
University Hospital, Basel, Switzerland 100
Not applicableStudy completedNCT02668614
What this trial is testing

Early Detection of Skin Cancer With Sensor Technology

Who this might be right for
Carcinoma, Basal Cell
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)Study completedNCT02550678
What this trial is testing

The Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Nevus SyndromeSkin NeoplasmNodular Basal Cell Carcinoma of Skin
Ascend Biopharmaceuticals Ltd 16
Testing effectiveness (Phase 2)Looking for participantsNCT07010692
What this trial is testing

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Who this might be right for
Keratinocyte CarcinomaBasal Cell CarcinomasSquamous Cell Carcinoma+1 more
Bruce Robinson, MD 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT06690086
What this trial is testing

DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

Who this might be right for
Skin Cancer
DermaSensor, Inc. 1,028
Not applicableLooking for participantsNCT06384924
What this trial is testing

Raman Spectroscopy and Skin Cancer

Who this might be right for
Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Tiezhi Zhang 20
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Large-scale testing (Phase 3)Ended earlyNCT00049959
What this trial is testing

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Who this might be right for
Basal Cell CarcinomaNevoid Basal Cell Carcinoma SyndromeGorlin Syndrome
QLT Inc.
Not applicableStudy completedNCT00836342
What this trial is testing

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Who this might be right for
Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Massachusetts General Hospital 81
Testing effectiveness (Phase 2)UnknownNCT00003097
What this trial is testing

Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer

Who this might be right for
Non-Melanomatous Skin Cancer
Baylor College of Medicine 175
Not applicableEnded earlyNCT04688749
What this trial is testing

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Who this might be right for
Melanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more
Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Study completedNCT00002975
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin CancerPrecancerous Condition
Roswell Park Cancer Institute 180
Not applicableStudy completedNCT02310503
What this trial is testing

Spanish Registry of Mohs Surgery

Who this might be right for
Skin NeoplasmsCarcinoma, Basal CellCarcinoma, Squamous Cell+4 more
Fundación Academia Española de Dermatología 6,000
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Not applicableLooking for participantsNCT06907095
What this trial is testing

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Who this might be right for
Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris 5,909
Testing effectiveness (Phase 2)Study completedNCT01327053
What this trial is testing

A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Novartis Pharmaceuticals 230
Next Page